Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further grow the business. The cancer diagnostics company, which once applied …